<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Direxion Shares Etf Trust - Direxion Daily Aapl Bear 1x Shares — News on 6ix</title>
<link>https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares</link>
<description>Latest news and press releases for Direxion Shares Etf Trust - Direxion Daily Aapl Bear 1x Shares on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 02 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares" rel="self" type="application/rss+xml" />
<item>
<title>Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium</title>
<link>https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/tvardi-therapeutics-to-participate-in-the-raymond-james-biotech-innovation-symposium-43</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/tvardi-therapeutics-to-participate-in-the-raymond-james-biotech-innovation-symposium-43</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>HOUSTON, April 02, 2026 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc. (“Tvardi”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the</description>
</item>
<item>
<title>European Wax Center's EWC TREAT® Dual-Sided Dry Brush Wins 2026 NewBeauty Award</title>
<link>https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/european-wax-centers-ewc-treatr-dual-sided-dry-brush-wins-2026-newbeauty-award-32</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/european-wax-centers-ewc-treatr-dual-sided-dry-brush-wins-2026-newbeauty-award-32</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>PLANO, Texas, April 2, 2026 /PRNewswire/ -- European Wax Center, Inc. (NASDAQ: EWCZ), the leading franchisor and operator of out-of-home waxing services, is</description>
</item>
<item>
<title>Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board</title>
<link>https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/harmony-biosciences-strengthens-executive-team-with-new-appointment-and-announces-additions-to-its-board-36</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/harmony-biosciences-strengthens-executive-team-with-new-appointment-and-announces-additions-to-its-board-36</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Appointments support Harmony’s next phase of growth and long‑term value creation PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)-- Harmony Biosciences Holdings, Inc.</description>
</item>
<item>
<title>Wingstop Inc. to Announce Fiscal First Quarter 2026 Financial Results on April 29, 2026</title>
<link>https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/wingstop-inc-to-announce-fiscal-first-quarter-2026-financial-results-on-april-29-2026-53</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/wingstop-inc-to-announce-fiscal-first-quarter-2026-financial-results-on-april-29-2026-53</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>DALLAS, April 2, 2026 /PRNewswire/ -- Wingstop Inc. (NASDAQ: WING) today announced that it will host a conference call and webcast to discuss its fiscal first</description>
</item>
<item>
<title>Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression</title>
<link>https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/lipocine-reports-topline-safety-and-efficacy-results-for-lpcn-1154-in-patients-with-postpartum-depression-36</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/lipocine-reports-topline-safety-and-efficacy-results-for-lpcn-1154-in-patients-with-postpartum-depression-36</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>In the Phase 3 study population (N=90) of patients with PPD, LPCN 1154 did not show a statistically significant reduction from baseline in HAM-D17 total score</description>
</item>
<item>
<title>Letter to Shareholders from Marcus Lemonis, Executive Chairman and CEO: The Growth Phase</title>
<link>https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/letter-to-shareholders-from-marcus-lemonis-executive-chairman-and-ceo-the-growth-phase-47</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/letter-to-shareholders-from-marcus-lemonis-executive-chairman-and-ceo-the-growth-phase-47</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>MURRAY, Utah--(BUSINESS WIRE)-- Bed Bath & Beyond, Inc. (NYSE: BBBY) (“Bed Bath & Beyond” or “BBBY”) has issued the following letter from Marcus Lemonis,</description>
</item>
<item>
<title>Orrstown Financial Services, Inc. Ranked #1 in Pennsylvania and #12 Nationally in the S&P Global Market Intelligence 2025 Ranking of Top 50 Best-Performing Community Banks</title>
<link>https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/orrstown-financial-services-inc-ranked-1-in-pennsylvania-and-12-nationally-in-the-sandp-global-market-intelligence-2025-ranking-of-top-50-best-performing-community-banks-35</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/orrstown-financial-services-inc-ranked-1-in-pennsylvania-and-12-nationally-in-the-sandp-global-market-intelligence-2025-ranking-of-top-50-best-performing-community-banks-35</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>HARRISBURG, Pa., April 02, 2026 (GLOBE NEWSWIRE) -- Orrstown Financial Services, Inc. (the “Company”) (NASDAQ: ORRF), the holding company for Orrstown Bank,</description>
</item>
<item>
<title>Braiin and Home Announce Exclusive Strategic Partnership to Pioneer "LiveTech" and Build AI-Native Living Infrastructure Platform</title>
<link>https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/braiin-and-home-announce-exclusive-strategic-partnership-to-pioneer-livetech-and-build-ai-native-living-infrastructure-platform</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/braiin-and-home-announce-exclusive-strategic-partnership-to-pioneer-livetech-and-build-ai-native-living-infrastructure-platform</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>A category-defining partnership combining AI, payments and embedded distribution NEW YORK, NY AND LONDON, UK / ACCESS Newswire / April 2, 2026 / Braiin</description>
</item>
<item>
<title>Freshworks Expands IT Asset Management Capabilities by Adding Continuous Infrastructure Discovery and Dependency Mapping to Freshservice</title>
<link>https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/freshworks-expands-it-asset-management-capabilities-by-adding-continuous-infrastructure-discovery-and-dependency-mapping-to-freshservice-41</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/freshworks-expands-it-asset-management-capabilities-by-adding-continuous-infrastructure-discovery-and-dependency-mapping-to-freshservice-41</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>New ITAM product provides visibility into how infrastructure supports the services that businesses depends onSAN MATEO, Calif., April 02, 2026 (GLOBE</description>
</item>
<item>
<title>Academy Sports + Outdoors Announces Participation in Upcoming Investor Conference</title>
<link>https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/academy-sports-outdoors-announces-participation-in-upcoming-investor-conference-42</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/academy-sports-outdoors-announces-participation-in-upcoming-investor-conference-42</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>KATY, Texas, April 2, 2026 /PRNewswire/ -- Academy Sports + Outdoors ("Academy" or the "Company") (Nasdaq: ASO), a leading full-line sporting goods and</description>
</item>
<item>
<title>Nanalysis Announces Fourth Quarter and Full Year 2025 Conference Call</title>
<link>https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/nanalysis-announces-fourth-quarter-and-full-year-2025-conference-call-42</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/nanalysis-announces-fourth-quarter-and-full-year-2025-conference-call-42</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Hosting Call at 10am ET on Thursday, April 9thCALGARY, AB, April 2, 2026 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, FRA: 1N1), a</description>
</item>
<item>
<title>SABINE ROYALTY TRUST ANNOUNCES MONTHLY CASH DISTRIBUTION FOR APRIL 2026</title>
<link>https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/sabine-royalty-trust-announces-monthly-cash-distribution-for-april-2026-37</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/sabine-royalty-trust-announces-monthly-cash-distribution-for-april-2026-37</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>DALLAS, April 2, 2026 /PRNewswire/ -- Argent Trust Company, as Trustee of the Sabine Royalty Trust (NYSE: SBR), today declared a cash distribution to the</description>
</item>
<item>
<title>Xeriant Receives U.S. Patent Notice Allowance for its Breakthrough Fire-Resistant Composite Technology</title>
<link>https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/xeriant-receives-us-patent-notice-allowance-for-its-breakthrough-fire-resistant-composite-technology-38</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/xeriant-receives-us-patent-notice-allowance-for-its-breakthrough-fire-resistant-composite-technology-38</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Positions the Company at the forefront of next-generation building materials BOCA RATON, Fla., April 02, 2026 (GLOBE NEWSWIRE) -- Xeriant, Inc. (OTCQB: XERI),</description>
</item>
<item>
<title>Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive</title>
<link>https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/cocrystal-pharma-receives-fda-fast-track-designation-for-cdi-988-for-norovirus-infection-treatment-and-preventive-43</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/cocrystal-pharma-receives-fda-fast-track-designation-for-cdi-988-for-norovirus-infection-treatment-and-preventive-43</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>FDA Fast Track designation supports accelerated development and expedites regulatory reviewNorovirus is responsible for an estimated 685 million global cases</description>
</item>
<item>
<title>Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company</title>
<link>https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/curanex-expands-its-drug-development-pipeline-to-include-cancer-cachexia-representing-a-multi-billion-dollar-market-opportunity-and-important-step-in-the-companys-evolution-into-a-broader-therapeutics-development-company-29</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/curanex-expands-its-drug-development-pipeline-to-include-cancer-cachexia-representing-a-multi-billion-dollar-market-opportunity-and-important-step-in-the-companys-evolution-into-a-broader-therapeutics-development-company-29</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Company expands strategic focus into one of oncology’s most urgent supportive-care challenges Jericho, New York, April 02, 2026 (GLOBE NEWSWIRE) -- Curanex</description>
</item>
<item>
<title>PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio</title>
<link>https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/pavmed-appoints-joseph-virgilio-to-lead-relaunched-medical-device-portfolio-33</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/pavmed-appoints-joseph-virgilio-to-lead-relaunched-medical-device-portfolio-33</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Medtech industry veteran to oversee development and commercialization of PAVmed's current and future medical device portfolio.Octeris, Inc. subsidiary formed</description>
</item>
<item>
<title>PureTech Announces Publication of Phase 2b ELEVATE IPF Trial Results in The American Journal of Respiratory and Critical Care Medicine</title>
<link>https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/puretech-announces-publication-of-phase-2b-elevate-ipf-trial-results-in-the-american-journal-of-respiratory-and-critical-care-medicine-3</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/puretech-announces-publication-of-phase-2b-elevate-ipf-trial-results-in-the-american-journal-of-respiratory-and-critical-care-medicine-3</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Deupirfenidone 825 mg TID monotherapy significantly slowed lung function decline versus placebo at 26 weeks in people with idiopathic pulmonary fibrosis</description>
</item>
<item>
<title>Nanox Signs Distribution Agreement with Integrity Medical Service, Inc. to Deploy Nanox.ARC Systems</title>
<link>https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/nanox-signs-distribution-agreement-with-integrity-medical-service-inc-to-deploy-nanoxarc-systems-16</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/nanox-signs-distribution-agreement-with-integrity-medical-service-inc-to-deploy-nanoxarc-systems-16</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>New regional partnership strengthens Nanox’s presence and service support across outpatient imaging settings in Colorado, Wyoming and the western parts of</description>
</item>
<item>
<title>Guidefitter Deepens Strategic Partnership with Rocky Brands, Inc., Expands Platform to Include Muck and XTRATUF</title>
<link>https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/guidefitter-deepens-strategic-partnership-with-rocky-brands-inc-expands-platform-to-include-muck-and-xtratuf-14</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/guidefitter-deepens-strategic-partnership-with-rocky-brands-inc-expands-platform-to-include-muck-and-xtratuf-14</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Expansion Builds on Longstanding Collaboration with Rocky Boots, Bringing Additional Rocky Brands Portfolio Leaders into Guidefitter's Professional</description>
</item>
<item>
<title>LightInTheBox Files 2025 Annual Report on Form 20-F</title>
<link>https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/lightinthebox-files-2025-annual-report-on-form-20-f-51</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-shares-etf-trust-direxion-daily-aapl-bear-1x-shares/news/lightinthebox-files-2025-annual-report-on-form-20-f-51</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>SINGAPORE, April 2, 2026 /PRNewswire/ -- LightInTheBox Holding Co., Ltd. (NYSE: LITB) ("LightInTheBox" or the "Company"), a global consumer lifestyle company,</description>
</item>
</channel>
</rss>